Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Impact of abdominal obesity and ambulatory blood pressure in the diagnosis of left ventricular hypertrophy in never treated hypertensives.

Rodilla E, Costa JA, Martín J, González C, Pascual JM, Redon J.

Med Clin (Barc). 2014 Mar 20;142(6):235-42. doi: 10.1016/j.medcli.2013.04.046. Epub 2013 Oct 16.

PMID:
24139053
2.

Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass?

Gosse P, Jullien V, Jarnier P, Lemetayer P, Clementy J.

J Hum Hypertens. 1999 Aug;13(8):505-9.

3.

Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives?

Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, Zanchetti A, Mancia G.

J Hum Hypertens. 2009 Nov;23(11):728-34. doi: 10.1038/jhh.2009.16. Epub 2009 Mar 26.

PMID:
19322202
4.
5.

Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians.

Salako BL, Ogah OS, Adebiyi AA, Oladapo OO, Aje A, Adebayo AK, Ojji DB, Ipadeola A, Nwafor CE.

Ann Afr Med. 2009 Jul-Sep;8(3):156-62. doi: 10.4103/1596-3519.57237.

6.

Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure.

Woodiwiss AJ, Libhaber CD, Majane OH, Libhaber E, Maseko M, Norton GR.

Am J Hypertens. 2008 Oct;21(10):1144-51. doi: 10.1038/ajh.2008.252. Epub 2008 Aug 28.

PMID:
18756261
7.

Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.

Cerasola G, Nardi E, Mulè G, Palermo A, Cusimano P, Guarneri M, Arsena R, Giammarresi G, Carola Foraci A, Cottone S.

Nephrology (Carlton). 2010 Mar;15(2):203-10. doi: 10.1111/j.1440-1797.2009.01178.x.

PMID:
20470280
8.

Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study.

De Jong KA, Czeczor JK, Sithara S, McEwen K, Lopaschuk GD, Appelbe A, Cukier K, Kotowicz M, McGee SL.

Cardiovasc Diabetol. 2017 Feb 8;16(1):21. doi: 10.1186/s12933-017-0504-z. Erratum in: Cardiovasc Diabetol. 2017 Apr 20;16(1):53.

9.

Indexation criteria of ventricular mass and predictive role of blood pressure and body composition.

Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A.

Am J Hypertens. 2005 Oct;18(10):1282-7.

PMID:
16202849
10.

Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.

Salvetti G, Pucci A, Fierabracci P, Ceccarini G, Palagi C, Delle Donne MG, Di Bello V, Piaggi P, Vitti P, Salvetti A, Pinchera A, Santini F.

High Blood Press Cardiovasc Prev. 2012 Mar 1;19(1):33-9. doi: 10.2165/11593700-000000000-00000.

PMID:
22670585
11.

Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.

Verdecchia P, Angeli F, Mazzotta G, Bartolini C, Garofoli M, Aita A, Poltronieri C, Pinzagli MG, Valecchi F, Martone S, Ramundo E, Turturiello D, Reboldi G.

J Am Heart Assoc. 2017 May 24;6(6). pii: e005948. doi: 10.1161/JAHA.117.005948.

12.

Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass.

Vitale G, Galderisi M, Pivonello R, Spinelli L, Ciccarelli A, de Divitiis O, Lombardi G, Colao A.

Clin Endocrinol (Oxf). 2004 Mar;60(3):343-9.

PMID:
15009000
13.

Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study.

de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, Lee ET, Devereux RB; Strong Heart Study Investigators.

Am J Hypertens. 2005 Feb;18(2 Pt 1):191-6.

PMID:
15752946
14.

Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: the St. Petersburg study.

Conrady AO, Rudomanov OG, Zaharov DV, Krutikov AN, Vahrameeva NV, Yakovleva OI, Alexeeva NP, Shlyakhto EV.

Blood Press. 2004;13(2):101-9.

PMID:
15182113
15.

Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children.

Jing L, Nevius CD, Friday CM, Suever JD, Pulenthiran A, Mejia-Spiegeler A, Kirchner HL, Cochran WJ, Wehner GJ, Chishti AS, Haggerty CM, Fornwalt BK.

J Cardiovasc Magn Reson. 2017 Nov 9;19(1):86. doi: 10.1186/s12968-017-0401-3.

16.

Reduced nocturnal fall in blood pressure, assessed by two ambulatory blood pressure monitorings and cardiac alterations in early phases of untreated essential hypertension.

Cuspidi C, Michev I, Meani S, Severgnini B, Fusi V, Corti C, Salerno M, Valerio C, Magrini F, Zanchetti A.

J Hum Hypertens. 2003 Apr;17(4):245-51.

PMID:
12692569
17.

Anthropometric measures of increased central and overall adiposity in association with echocardiographic left ventricular hypertrophy.

Rodrigues SL, Baldo MP, Sá Cunha R, Angelo LC, Pereira AC, Krieger JE, Mill JG.

Hypertens Res. 2010 Jan;33(1):83-7. doi: 10.1038/hr.2009.188. Epub 2009 Nov 13.

PMID:
19911003
18.

Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control.

Cuspidi C, Lonati L, Sampieri L, Michev I, Macca G, Rocanova JI, Salerno M, Fusi V, Leonetti G, Zanchetti A.

J Hypertens. 2000 Jun;18(6):803-9.

PMID:
10872567
19.

Left ventricular geometry in children and adolescents with primary hypertension.

Richey PA, Disessa TG, Somes GW, Alpert BS, Jones DP.

Am J Hypertens. 2010 Jan;23(1):24-9. doi: 10.1038/ajh.2009.164. Epub 2009 Oct 22.

20.

Supplemental Content

Support Center